HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

On the edge: targeting Toll-like receptor 2 in ischemia/reperfusion injury.

AuthorsPhilipp M Lepper, Robert Bals
JournalCirculation. Cardiovascular interventions (Circ Cardiovasc Interv) Vol. 5 Issue 2 Pg. 146-9 (Apr 2012) ISSN: 1941-7632 [Electronic] United States
PMID22511737 (Publication Type: Editorial, Comment)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Toll-Like Receptor 2
Topics
  • Animals
  • Antibodies, Monoclonal, Humanized (administration & dosage)
  • Female
  • Heart (drug effects)
  • Humans
  • Myocardial Infarction (drug therapy)
  • Myocardium (metabolism)
  • Reperfusion Injury (prevention & control)
  • Toll-Like Receptor 2 (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: